To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
1-800-KARMANOS (1-800-527-6266)
The Karmanos Cancer Institute at The Toledo Clinic Cancer Center in Maumee is a state-of-the-art health care campus that provides outstanding patient-centered care and delivers new life-changing cancer therapies and treatments, within miles for nearby residents.
Under this partnership, Karmanos operates the radiation oncology program, advanced cancer care services and clinical trials at the new freestanding cancer center. Together, our joint teams will advance the fight against cancer in Lucas County.
The cancer center is a centerpiece of Side Cut Crossings, a 58-acre development off the Anthony Wayne Trail between Ford Street and Monclova Road.
Oncology - Radiation
Oncology - Surgical
Josephine Roach
Karmanos Cancer Institute
Bob Busch
Elfia Blake
A new drug has received U.S. Food and Drug Administration (FDA) approval, in which the Barbara Ann Karmanos Cancer Institute played a crucial role...
“I knew if this treatment was going to help me, I would drive wherever to get it.” Living in Cadillac, David Levine was an avid hunter and outdoor...
Over the last decade, melanoma survival rates have improved significantly due to ongoing research and the development of immunotherapy. Lifileucel...